UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007215 |
|---|---|
| Receipt number | R000008487 |
| Scientific Title | A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer |
| Date of disclosure of the study information | 2012/02/02 |
| Last modified on | 2017/08/07 10:00:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer
Acronym
A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer
Scientific Title
A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer
Scientific Title:Acronym
A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer
Region
| Japan |
Condition
Condition
non-small-cell lung cancer(Excluding squamous call lung cancer)
Classification by specialty
| Medicine in general | Pneumology | Surgery in general |
| Chest surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to evaluate the efficacy and safety of practical treatment combined with Bevacizumab in patients.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Phase IV
Assessment
Primary outcomes
Efficacy and safety(Time to Treatment Failure)
Key secondary outcomes
Individual side effect and efficacy,Response rate,Overall survival
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients who received bevacizumab containing chemotherapy.
Key exclusion criteria
none.
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoichi Nakamura |
Organization
Nagasaki University Hospital
Division name
Second department of internal medicine
Zip code
Address
1-7-1 , Sakamoto, nagasaki, Nagasaki, Japan
TEL
0958197273
yi-nakamu@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yoichi Nakamura |
Organization
Nagasaki University Hospital
Division name
Second department of internal medicine
Zip code
Address
1-7-1 , Sakamoto, nagasaki, Nagasaki, Japan
TEL
0958197273
Homepage URL
yi-nakamu@umin.ac.jp
Sponsor or person
Institute
Nagasaki thoracic oncology group
Institute
Department
Personal name
Funding Source
Organization
None.
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 02 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2011 | Year | 10 | Month | 30 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 01 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Multicenter retrospective cohort study
Management information
Registered date
| 2012 | Year | 02 | Month | 02 | Day |
Last modified on
| 2017 | Year | 08 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008487
